Cryoablation technology manufacturer IceCure Medical has received a Notice of Allowance from the US Patent and Trademark Office for its cryogen pump.
A new generation cryoablation system, the cryogenic pump is designed to be used for multiple procedures or longer duration procedures without the need to refill liquid nitrogen.
To do this, the innovation is submersible in liquid nitrogen, works in a closed circuit, enables temperature control of the cryoprobe and improves the cooling rate during a procedure.
Eyal Shamir, CEO of IceCure, believes the Notice of Allowance is well timed to protect its intellectual property as the company develops next generation cryoablation systems to perform minimally invasive procedures for new indications.
... to continue reading you must be subscribed
